Clinical Quality Indicators
|
|
- Jeffry Sherman
- 6 years ago
- Views:
Transcription
1 Clinical Quality Indicatrs Patients currently n PrEP Patients currently n PrEP Definitins: Eligibility: Any patient wh has been prescribed PrEP during the review perid. Risk Assessment Prprtin f patients wh received a risk assessment regarding histry f cndm usage, STI, intravenus drug use, transactinal sex, and Nn-ccupatinal Pst-Expsure Prphylaxis (npep) at baseline and every 4 mnths afterwards. All patients Number f patients wh received a risk assessment at least every 4 mnths Risk assessments include: Cndm usage STI histry Intravenus drug use histry Transactinal sex histry Nn-ccupatinal Pst-Expsure Prphylaxis (npep) histry HIV Testing Prprtin f patients wh received an HIV test at baseline and every 4 mnths afterwards. All patients Number f patients wh received an HIV test at baseline and at least every 4 mnths HIV Sercnversin Prprtin f patients wh test psitive fr HIV. All patients wh were tested fr HIV Number f patients wh test psitive fr HIV while n PrEP STI Screening Prprtin f patients wh received a syphilis, gnrrhea, and chlamydia tests at baseline and every 4 mnths. All patients Number f patients wh received syphilis, gnrrhea, and chlamydia tests at baseline and at least every 4 mnths
2 Rectal Chlamydia Testing Prprtin f patients wh received a rectal chlamydia test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal chlamydia at least every 4 mnths Rectal Gnrrhea Testing Prprtin f patients wh received a rectal gnrrhea test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal gnrrhea at least every 4 mnths Pharyngeal Gnrrhea Testing Prprtin f patients wh received a pharyngeal gnrrhea test every 4 mnths. All patients engaging in ral sex Number f patients wh were tested fr pharyngeal gnrrhea at least every 4 mnths Renal Functin Screening Prprtin f patients whse renal functin was assessed fr serum creatinine at baseline and every 6 mnths. All patients Number f patients wh received a serum creatinine test at baseline and every 6 mnths Urinalysis Prprtin f patients wh received a urinalysis at baseline and every 6 mnths. All patients Number f patients wh received a urinalysis at baseline and every 6 mnths Adherence Assessment Prprtin f patients wh received an adherence assessment every 4 mnths. All patients Number f patients wh received an adherence assessment every 4 mnths Mental Health Screening Prprtin f patients wh received a baseline and annual mental health screening. All patients Number f patients wh received a baseline and annual mental health screening
3 Substance Abuse Screening Prprtin f patients wh received a baseline and annual substance abuse screening. All patients Number f patients wh received a baseline and annual substance abuse screening Dmestic Vilence Screening Prprtin f patients wh received a baseline and annual dmestic vilence screening. All patients Number f patients wh received a baseline and annual dmestic vilence screening Linkage t care Prprtin f patients wh sercnverted and were linked t HIV care within 5 days. All patients wh sercnverted Number f patients wh were linked t HIV care within 5 days f sercnversin
4 Patients wh have nt started PrEP Patients wh have nt started PrEP Eligibility: Patients wh have nt been prescribed PrEP but are currently enrlled in the PrEP prgram during the review perid. Risk Assessment Prprtin f patients wh received a risk assessment regarding histry f cndm usage, STI, intravenus drug use, transactinal sex, and Nn-ccupatinal Pst-Expsure Prphylaxis (npep) at baseline and every 4 mnths afterwards. All patients Number f patients wh received a risk assessment at least every 4 mnths Risk assessments include: Cndm usage STI histry Intravenus drug use histry Transactinal sex histry Nn-ccupatinal Pst-Expsure Prphylaxis (npep) histry HIV Testing Prprtin f patients wh received an HIV test every 4 mnths. All patients Number f patients wh received an HIV test at least every 4 mnths HIV Testing: HIV Sercnversin (nt n PrEP) Prprtin f patients testing psitive fr HIV. All patients wh were tested fr HIV Number f patients wh test psitive fr HIV Exclusins: Patients with a knwn HIV infectin. Linkage t care (Sercnversins) Prprtin f patients wh sercnverted and were linked t HIV care within 5 days. All patients wh sercnverted Number f patients wh were linked t HIV care within 5 days f sercnversin STI Screening Prprtin f patients wh received a syphilis, gnrrhea, and chlamydia tests at baseline and every 4 mnths.
5 All patients Number f patients wh received syphilis, gnrrhea, and chlamydia tests at baseline and at least every 4 mnths Rectal Chlamydia Testing Prprtin f patients wh received a rectal chlamydia test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal chlamydia at least every 4 mnths Rectal Gnrrhea Testing Prprtin f patients wh received a rectal gnrrhea test every 4 mnths. All patients engaging in anal sex Number f patients wh were tested fr rectal gnrrhea at least every 4 mnths Pharyngeal Gnrrhea Testing Prprtin f patients wh received a pharyngeal gnrrhea test every 4 mnths. All patients engaging in ral sex Number f patients wh were tested fr pharyngeal gnrrhea at least every 4 mnths
6 General Clinic-Specific Quality Indicatrs Clinic level Indicatrs Clinic Level Eligibility: Patients are thse wh: Are in a serdiscrdant relatinships Reprt having cndmless sex Had an STI within the past 6 mnths Have injected drugs within the past 6 mnths Identify as transgender and engage in high-risk sex Engage in transactinal sex Have been prescribed nn-ccupatinal pst-expsure prphylaxis (npep). Rutine Offering f PrEP Prprtin f at risk patients wh were ffered PrEP. All patients Number f patients wh were ffered PrEP services Patient Experience Indicatrs Patient Experience Eligibility: All patients enrlled in the PrEP prgram. Patient Experience Prprtin f patients wh were assessed fr experience. All patients Number f patients were assessed fr experience Stigma Prprtin f patients wh reprted experiences f stigma when receiving PrEP services. All patients Number f patients wh reprted experiences f stigma assciated with receiving PrEP services Access t Medicatin Prprtin f patients reprting gaps in medicatin adherence. All patients wh have been prescribed PrEP Number f patients wh reprted gaps in medicatin adherence
7 Organizatinal Metrics Organizatinal Indicatrs Onging Staff Training Staff receiving annual PrEP training. All staff prviding HIV care Number f staff that receive annual PrEP training Stigma Reductin Training Staff receiving annual stigma reductin training. All staff prviding HIV care Number f staff that receive annual stigma reductin training Referral and Linkage Prprtin f patients wh were linked t primary care after stpping PrEP. Patients that have stpped taking PrEP within the review perid Number f patients that are linked and referred t primary care Exclusins: Sites with an integrated PrEP and primary care prgram. Lst t Care Prprtin f patients wh were reengaged in care after missing 2 r mre cnsecutive PrEP clinical appintments. All PrEP patients wh have missed 2 r mre cnsecutive PrEP clinical appintments Number f patients reengaged in care
8 Ppulatin Indicatrs Patients with STIs Prprtin f patients wh test psitive fr STIs. All patients receiving services in a PrEP prgram Number f STIs Incidence rate f STIs fr PrEP patients. All patients receiving services in a PrEP prgram Number f patients wh test psitive fr STIs Number f cnfirmed unique diagnses f STIs Linkage t Care Prprtin f identified PrEP eligible patients wh were linked t PrEP services. Patients wh: Number f patients wh were linked t Are in a serdiscrdant relatinships PrEP services Reprt having cndmless sex Had an STI within the past 6 mnths Have injected drugs within the past 6 mnths Identify as transgender and engage in highrisk sex Engage in transactinal sex Have been prescribed nn-ccupatinal pstexpsure prphylaxis (npep).
US Public Health Service Clinical Practice Guidelines for PrEP
Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S
More informationiprex Fact Sheet: Key Results
EMBARGOED UNTIL RELEASE Tuesday, 23 Nvember 2010, 8 a.m. EST CONTACT Mark Aurigemma; 646-270-9451; mark@aucmm.net Pedr Gicchea; 415-490-8350 pgicchea@gladstne.ucsf.edu iprex Fact Sheet: Key Results iprex
More informationPrEP Home Checklist v1.0
PrEP Home Checklist v1.0 Every Visit o Risk Reduction Counseling o Appropriate referrals and follow-ups (SW, Pharmacy, et al.) o For those on PrEP: o Assessment of PrEP adherence, side effects, ongoing
More informationWaterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION
Waterl Wellingtn Rehabilitative Care System Integrated Care Pathway fr STROKE Stream f Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION Care Setting Activity Patients wh present t a cmmunity
More informationIowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training
Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.
More informationTable of Contents (Click on title to jump to section)
Table f Cntents (Click n title t jump t sectin) Overviews: Pre-pubertal (tanner 1,2) Assault Quick Guide Pst-pubertal (tanner 3,4,5) Assault Quick Guide Sectins: Pre-pubertal 1) Acute Assault 2) Sub-acute
More informationEvaluation of Hunter & New England HealthPathways
Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%
More informationHealth Screening Record: Entry Level Due: August 1st MWF 150 Entry Year
Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic
More informationCDC Influenza Technical Key Points February 15, 2018
CDC Influenza Technical Key Pints In this dcument: Summary Key Pints U.S. Vaccine Effectiveness U.S. Flu Activity Update Summary Key Pints On Thursday, tw influenza-related reprts appeared in the Mrbidity
More informationCenter for Circulatory Support. The Center for Circulatory Support strives for continuous improvement in quality and patient outcomes
Palliative Care Cnsults: Centers fr Medicare and Medicaid Services Decisin Mem fr Ventricular Assist Devices fr Bridge-t-Transplant and Destinatin Therapy Center fr Circulatry Supprt The Center fr Circulatry
More informationChapter 6: Impact Indicators
Overview Chapter 6: Impact Indicatrs The best measure f the lng-term impact f all HIV preventin activities is the HIV incidence rate, namely the number f new cases f HIV infectin per year divided by the
More informationMEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache
MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache Measure Descriptin All patients diagnsed with migraine headache r cervicgenic headache wh had a headache management
More informationSignificance of Chronic Kidney Disease in 2015
1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care
More informationTrillium and Willamette Dental Group: Dental-Medical Diabetes Management and Care Coordination
Trillium and Willamette Dental Grup: Dental-Medical Diabetes Management and Care Crdinatin Grant Prpsal Willamette Dental Grup (WDG) was awarded $117,024 as part f Trillium s Transfrmatin Grant Prgram:
More informationThe research question: What was discovered in the 1940s that could treat syphilis?
Psychlgy B30 Human Sexuality Sexually Transmitted Infectins Tuskegee Syphilis Experiment Ppulatin: The research questin: What was discvered in the 1940s that culd treat syphilis? Hw many men died f syphilis
More informationHuman papillomavirus (HPV) refers to a group of more than 150 related viruses.
HUMAN PAPILLOMAVIRUS This infrmatin may help answer sme f yur questins and help yu think f ther questins that yu may want t ask yur cancer care team; it is nt intended t replace advice r discussin between
More informationHPV VACCINATION IN SANDYFORD SERVICES
HPV VACCINATION IN SANDYFORD SERVICES 1. General infrmatin n HPV Vaccinatin 2. HPV vaccinatin in females 3. Yung Wmen Only 4. HPV vaccinatin in MSM 1. General infrmatin General Infrmatin fr clinicians
More informationBreast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)
Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages
More informationCoronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)
Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD
More informationACRIN 6666 Screening Breast US Follow-up Assessment Form
Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related
More informationCDC Influenza Division Key Points MMWR Updates February 20, 2014
CDC Influenza Divisin Key Pints MMWR Updates In this dcument: Summary Key Messages Seasnal Influenza Vaccine Effectiveness: Interim Adjusted Estimates Influenza Surveillance Update: September 29, 2013-February
More informationChronic Fatigue Syndrome
Chrnic Fatigue Syndrme (Als knwn as Myalgic encephalmyelitis/encephalmyelpathy) What is CFS/ME? CFS/ME cmprises a range f symptms that include fatigue, malaise, headaches, sleep disturbances, difficulties
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential
More informationDiabetes: HbA1c Poor Control (NQF 0059)
Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December
More informationHearing Service Fees and Fee Codes Effective: January 01, 2019
Hearing Fees and Fee Cdes Effective: January 01, 2019 The WCB will fund the fllwing hearing services fr claims accepted fr traumatic and ccupatinal nise induced hearing: Fee cde 200 - Full audilgical assessment.
More informationHeart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or
Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): Angitensin
More informationImplementation of Early retention monitoring of HIV positive pregnant and breastfeeding women; and data use in the EMTCT program MOH-UGANDA
Implementatin f Early retentin mnitring f HIV psitive pregnant and breastfeeding wmen; and data use in the EMTCT prgram MOH-UGANDA Presentatin utline Backgrund Methdlgy Issues addressed Challenges identified
More informationReferral Criteria: Inflammation of the Spine Feb
Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses
More informationNATIONAL GUIDELINES ON THE USE OF ANTIRETROVIRAL THERAPY FOR HIV PREVENTION AND TREATMENT
NATIONAL GUIDELINES ON THE USE OF ANTIRETROVIRAL THERAPY FOR HIV PREVENTION AND TREATMENT Fifth Editin Ministry f Health Gvernment f Lesth April 2016 TABLE OF CONTENTS TABLE OF CONTENTS... i ABBREVIATIONS
More informationNonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer
Nnclinical factrs assciated with premature terminatin f adjuvant chemtherapy fr stage I-III breast cancer Xia-Cheng Wu, Trevr Thmpsn, Meichin Hsieh, Meijia Zhu, Patricia Andrews, Michelle Lch, Timthy Styles,
More information23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)
Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting
More informationHeart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or
Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): EMeasure
More information2017 CMS Web Interface
CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Fllw-Up Measure Steward: CMS Web Interface V1.0 Page 1 f 22 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE
More informationPrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute
PrEP for HIV Prevention Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the PrEP Guideline Raise awareness of PrEP among healthcare
More informationLyme Disease Surveillance in North Carolina
Lyme Disease Surveillance in Nrth Carlina 2008-2014 Carl Williams DVM Megan Sanza MPH Cmmunicable Disease Branch Divisin f Nrth Carlina Public Health Lyme Disease Surveillance in Nrth Carlina 2008-2014
More informationChild and Adult Preventive Care Services
Child and Adult Preventive Care Services Adult and Child Preventive Care Services will meet the requirements as determined by federal and state law. Cvered preventive care services prvided by a Participating
More informationWARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES
INDICATION FARYDAK (panbinstat) capsules, a histne deacetylase inhibitr, in cmbinatin with brtezmib and dexamethasne, is indicated fr the treatment f patients with multiple myelma wh have received at least
More informationTOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH
Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,
More informationSolid Organ Transplant Benefits to Change for Texas Medicaid
Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a
More informationHIV Diagnostic Tests. HIV Testing Algorithm at SydPath (National Reference Laboratory)
HIV Diagnstic Tests HIV Testing Algrithm at SydPath (Natinal Reference Labratry) HIV1/2 Ab/Ag Cmbi is Architect HIV- 1 Ab/Ag EIA is Genscreen Sandwich EIA 4 th Generatin HIV Ab/Ag Chemiluminescene Micr
More informationCOMMUNITY (NON-OCCUPATIONAL) BLOOD OR BODILY FLUID EXPOSURE
COMMUNITY (NON-OCCUPATIONAL) BLOOD OR BODILY FLUID EXPOSURE ALGORITHM 1. Sexual Assault Suspected r reprted sexual assault Cnsult scial wrk fr every case f suspected r reprted sexual assault Inclusin criteria:
More informationColorado Essential Health Benefit for Children
Smile fr Kids LOW EHB This summary f benefits, alng with the exclusins and limitatins describe the benefits f the Essential Health Benefit (EHB) fr Children. Please review clsely t understand all benefits,
More informationCognitive enhancers for the treatment of Alzheimer s disease
Cmprehensive Research Plan: Cgnitive enhancers fr the treatment f Alzheimer s disease Pharmacepidemilgy Unit February 13 th, 2015 30 Bnd Street, Trnt ON, M5B 1W8 www.dprn.ca inf@dprn.ca 2 ODPRN Drug Class
More informationTick fever is a cattle disease caused by any one of the following blood parasites:
Tick fever Tick fever is a cattle disease caused by any ne f the fllwing bld parasites: Babesia bvis Babesia bigemina Anaplasma marginale These parasites are all transmitted by the cattle tick (Bphilus
More informationSection 5. Study Procedures
Sectin 5. Study Prcedures 5.1 Visit Lcatins... 1 5.2 Eligibility Determinatin... 1 5.3 Screening Visit... 2 5.3.1 Screening and Enrllment Timeframe... 2 5.3.2 Screening Visit Prcedures... 2 5.3.3 Screening
More informationAlberta Health Public Health Notifiable Disease Management Guidelines April 2013
April 2013 Hepatitis A Revisin Dates Case Definitin Reprting Requirements Remainder f the Guideline (i.e., Etilgy t References sectins inclusive) Updated Prphylaxis Table and Algrithm (Pages 9, 12) Case
More information2018 CMS Web Interface
CMS Web Interface PREV-12 (NQF 0418): Preventive Care and Screening: Screening fr Depressin and Measure Steward: CMS CMS Web Interface V2.1 Page 1 f 23 06/25/ Cntents INTRODUCTION... 3 CMS WEB INTERFACE
More informationCOPD Outreach Program
COPD Outreach Prgram Wendy Laframbise, Advanced Practice Nurse Certified Respiratry Educatr COPD Outreach Prgram March, 2015 Disclaimer: The Canadian Fundatin fr Healthcare Imprvement (CFHI), in partnership
More informationNew London County Unified Intake for Homeless Families
New Lndn Cunty Unified Intake fr Hmeless Families Presentatin by Lisa Tepper Bates, Executive Directr Mystic Area Shelter & Hspitality (MASH) 2011 Snapsht: Family Hmelessness in Sutheastern CT Frm 2010
More informationHEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.
HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING Public Health Relevance Cervical cancer is 90% preventable by having regular Papaniclau (Pap) tests. The Pap test, als knwn as a cervical smear,
More informationBRCA1 and BRCA2 Mutations
BRCA1 and BRCA2 Mutatins ROBERT LEVITT, MD JESSICA BERGER-WEISS, MD ADRIENNE POTTS, MD HARTAJ POWELL, MD, MPH COURTNEY LEVENSON, MD LAUREN BURNS, MSN, RN, WHNP OBGYNCWC.COM v Cancer is a cmplex disease
More informationChoose to participate Enroll yourself and family members Waive coverage
Welcme t Open Enrllment. Open Enrllment is yur pprtunity t enrll r make changes t yur benefits fr the new plan year. During Open Enrllment yu may pt t d the fllwing: Chse t participate Enrll yurself and
More informationPennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain
Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre
More informationCommissioning Policy: South Warwickshire CCG (SWCCG)
Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding
More informationHCV exposure, infection and associated risk behaviours in two maximumsecurity prisons in NSW, Australia
HCV expsure, infectin and assciated risk behaviurs in tw maximumsecurity prisns in NSW, Australia Hajari B 1, Grebely J 1, Byrne M 1, Marks P 1, Butler T 1, Amin J 1, Vickerman P 2, Martin NK 2,3, McHutchisn
More informationGuidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:
Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes
More information<Date> <Group> <Address1> <Address2> <City> <State> <zip> RE: 2015 Blue Physician Recognition (BPR) Program. Dear <Group>:
Three Penn Plaza East Newark, NJ 07105-2200 HriznBlue.cm RE: 2015 Blue Physician Recgnitin (BPR) Prgram Dear : Hrizn Blue Crss Blue Shield
More informationAPPENDIX A Certification of Advanced Disease:
APPENDIX A Certificatin f Advanced Disease: Name: DOB: Member ID: Name f Palliative Care Prgram: A. General Criteria: Check each f the fllwing that apply (All needed fr eligibility). Patient wh is likely
More informationAdministrstrative Procedure
ELECTRONIC WORKING COPY VERIF. DATE: INITIALS: DIVISION: Envirnment, Safety, Health and Quality FUNCTIONAL AREA: Occupatinal Safety and Health SME: Garrick Schmburg Page 1 f 13 APPROVED BY/DATE: Steve
More informationCambridge Breast Unit Protocols for anticoagulant management prior to breast or axillary biopsies or excisions.
Prtcl CBU/POL/ JOINT POLICIES/008 Octber 2017 Prtcls fr anticagulant management prir t breast r axillary bipsies r excisins. 1. Scpe Fr use in the in bth screening and symptmatic breast services. 2. Purpse
More informationClinical Study Synopsis
Clinical Study Synpsis This Clinical Study Synpsis is prvided fr patients and healthcare prfessinals t increase the transparency f Bayer's clinical research. This dcument is nt intended t replace the advice
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synpsis fr Public Disclsure This clinical study synpsis is prvided in line with Behringer Ingelheim s Plicy n Transparency and Publicatin f Clinical Study Data. The synpsis which is
More information2018 Medical Association Poster Symposium Guidelines
2018 Medical Assciatin Pster Sympsium Guidelines Overview The 3 rd Annual student-run Medical Assciatin f the State f Alabama Research Sympsium will take place n Friday and Saturday, April 13-14 at the
More informationBilling Preventive Services June 6, 2017
Billing Preventive Services June 6, 2017 Disclaimer This resurce is nt a legal dcument. This presentatin was prepared as a tl t assist ur prviders. This presentatin was current at the time it was created.
More informationLTCH QUALITY REPORTING PROGRAM
4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04
More informationREFERRAL GUIDELINES Upper Gastro-Intestinal & Hepaticobilary
REFERRAL GUIDELINES Upper Gastr-Intestinal & Hepaticbilary Referral Frm: The GP Referral Template is the preferred referral tl (previusly knwn as the Victrian Statewide Referral Frm) GP Referral Template
More informationSUICIDE AND MENTAL ILLNESS IN SINGAPORE
Vl. 15, N. 3. SINGAPORE MEDICAL JOURNAL 191 September, 1974. SUICIDE AND MENTAL ILLNESS IN SINGAPORE By W. F. Tsi and B. H. Chia SYNOPSIS This is a study f 112 cases f suicides wh had a past histry f being
More informationMy Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)
My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made
More information2017 CMS Web Interface
CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY
More informationFTD RESEARCH: The Value of Studies and Opportunities for Involvement
FTD RESEARCH: The Value f Studies and Opprtunities fr Invlvement Sarah Lawrence, MS Research Prgram Manager Ann Fishman, MBA Sr. Research Crdinatr Weiyi Mu, ScM Genetic Cunselr Suzanne Dana Spuse/Caregiver
More informationLimitations and Exclusions (What is Not Covered)
Clrad Dental Family + Pediatric Plan Exclusins and Limitatins Limitatins and Exclusins (What is Nt Cvered) Excluded Services: Age 19 and lder Cvered Expenses d nt include expenses incurred fr: prcedures
More informationMEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion
MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new
More informationDiabetes Mellitus Lab Tests (Screening, Diagnosis & Monitoring)
Rule Categry: Medical ` Ref: N: 2013-MN-0012 Versin Cntrl: Versin N. 1.1 Effective Date: December 2013 Revisin Date: December 2014 Diabetes Mellitus Lab Tests (Screening, Diagnsis & Mnitring) Adjudicatin
More informationSmoking Cessation Improvement in SFHN Primary Care,
Smking Cessatin Imprvement in SFHN Primary Care, 2015-16 David Silven, PhD, Supervising Psychlgist, SFHN Primary Care Behaviral Health Ellen Chen, MD, Directr f Quality, SFHN Primary Care Why smking assessment
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationFast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs
Fast-Track Your PrEP Knowledge Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Session objectives Increase knowledge of the basics of PrEP and clinical procedures Identify financial
More informationMalaria 2025: Accelerate to Eliminate The Global Technical Strategy for Malaria: Setting global targets Azra Ghani, GTS Steering Committee
Malaria 2025: Accelerate t Eliminate The Glbal Technical Strategy fr Malaria: 2016-2025 Setting glbal targets Azra Ghani, GTS Steering Cmmittee Geneva, 12 March 2014 1 Visin and Gals Purpse f Visin and
More informationSwindon Joint Strategic Needs Assessment Bulletin
Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. Over the last several mnths, the United States has experienced a natinwide utbreak f entervirus D68 (EV- D68) assciated
More informationHoward E. Gary, Jr., Ray Sanders, and Mark A. Pallansch. Methods
S141 A Theretical Framewrk fr Evaluating the Sensitivity f Surveillance fr Detecting Wild Plivirus: II. Factrs Affecting Detectin Sensitivity in a Ppulatin with Circulating Wild Plivirus Hward E. Gary,
More informationOpioid Analgesics PA Request Provider Checklist
WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin
More informationAPESB and Auditor Independence
APESB and Auditr Independence Financial Reprting Cuncil Audit Quality Cmmittee 14 May 2014 Channa Wijesinghe MBA, FCPA, FCA Technical Directr Overview Rle f the Accunting Prfessinal & Ethical Standards
More informationDrug Therapy Guidelines
Applicable* Medical Benefit x Effective: 2/15/19 Pharmacy- Frmulary 1 Next Review: 12/19 Pharmacy- Frmulary 2 Date f Origin: 4/1/05 Pharmacy- Frmulary 3/Exclusive Review Dates: 4/1/05, 2/1/06, 10/15/06,
More informationTHE SOUTH AFRICAN ANTIRETROVIRALTREATMENT GUIDELINES 2013
THE SOUTH AFRICAN ANTIRETROVIRALTREATMENT GUIDELINES 2013 PMTCT GUIDELINES: REVISED MARCH 2013 Versin 0.2 13 March 2013 1 TABLE OF CONTENTS: 1. Executive summary 3 2. PMTCT prcesses and gals f interventin
More informationUrinary tract infection (lower) - women - Management
Urinary tract infectin (lwer) - wmen - Management Scenari: Cystitis in wmen wh are nt pregnant Hw shuld I manage a wman with suspected cystitis? Cnvey a psitive apprach and reassure the wman that cystitis
More informationChildhood Immunization Status (NQF 0038)
Childhd Immunizatin Status (NQF 0038) EMeasure Name Childhd Immunizatin EMeasure Id Pending Status Versin Number 1 Set Id Pending Available Date N infrmatin Measurement Perid January 1, 20xx thrugh December
More informationBritish Sign Language (BSL) Plan October 2018 Scottish Charity Regulator
British Sign Language (BSL) Plan 2018-2024 Octber 2018 Scttish Charity Regulatr Cntents Sectin 1: Intrductin and cntext 1.1 Intrductin 1.2 Our wrk and what we d Sectin 2: Our BSL Plan 2.1 Scttish Public
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Orencia (abatacept) Applicable Medical Benefit x Effective: 2/21/18 Pharmacy- Frmulary 1 x Next Review: 12/18 Pharmacy- Frmulary 2 x Date f Origin: 11/28/06 Pharmacy- Frmulary 3/Exclusive
More informationCardiac Rehabilitation Services
Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin
More informationKey Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.
Key Pints Entervirus D68 in the United States, 2014 Nte: Newly added infrmatin is in red. The United States is currently experiencing a natinwide utbreak f entervirus D68 (EV-D68) assciated with severe
More informationA. Catalonia World Health Organization Demonstration Project
A. Catalnia Wrld Health Organizatin Demnstratin Prject In 1989, the Health Department f Catalnia (Spain) and the Cancer Unit at the WHO (Geneva) designed and planned a demnstratin prject fr implementatin
More informationOsteoporosis Fast Facts
Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased
More informationGP Perspective about prescribing PEP & PrEP
GP Perspective about prescribing PEP & PrEP Dr Garsing Wong, Auckland Central Medical and Health Centre, 326/28 College Hill, Freemans Bay, Auckland 1011 akcentralmedical@gmail.com 09 360 0250 Disclosures
More informationIndependent Charitable Patient Assistance Program (IPAP) Code of Ethics
Independent Charitable Patient Assistance Prgram (IPAP) Cde f Ethics Independent charitable patient assistance prgrams (IPAPs) fcus n the needs f patients wh are insured, meet certain financial limitatin
More informationResponse to. type 2 vaccine-derived polioviruses. prior to global topv withdrawal. Interim Guidelines
Respnse t type 2 vaccine-derived pliviruses prir t glbal topv withdrawal Interim Guidelines August 2015 GPEI peratinal guidance nte August 2015 Summary Prepare fr prmpt actin fr any area r ppulatin at
More information2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizations, Clinical Cascade Breakout Session TB/HIV EXERCISE
2017 PEPFAR Data and Systems Applied Learning Summit Day 2: MER Analytics/Available Visualizatins, Clinical Cascade Breakut Sessin TB/HIV EXERCISE Created by the ICPI TB/HIV Wrkstream Abut this Handut
More informationMichigan Primary Care Transformation Project Performance Incentive Technical Manual
Michigan Primary Care Transfrmatin Prject 2016 Perfrmance Incentive Technical Manual Fr Physician Organizatins, Physician Hspital Organizatins, Independent Practice Assciatins and Primary Care Practices
More informationCONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW
FACT SHEET CONTACT: Amber Hamiltn 212-266-0062 TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW Type 2 diabetes accunts fr 90-95% f the 29.1 millin diabetes cases in the U.S. 1 Obesity is a majr independent
More informationDrug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD)
Drug Class Review: Lng-acting muscarinic antagnists (LAMAs) fr treatment f chrnic bstructive pulmnary disease (COPD) Cmprehensive Research Plan: Pharmacepidemilgy Unit April 10 th, 2014 ODPRN Drug Class
More informationGAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016
GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know
More information